Clinical trial
Comparison Of Two Tablet Formulations Of SB-568859
NCT00470145 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00470145 |
|---|---|
| Title | Comparison Of Two Tablet Formulations Of SB-568859 |
| Official title | A Randomised, Single Blind, 2 Period, Crossover Study to Compare the Single Dose Pharmacokinetics and Tolerability of Formulations Containing Unmilled and Micronised SB-568859 in Healthy Adults |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Atherosclerosis |
| Intervention type | Drug |
| Interventions | SB-568859 |
| Enrollment | 28 |
| Start date | Apr 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | May 7, 2007 |
| Last update posted | Jun 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: